ScienceDex / Researcher record
Lo, Donald
- National Center for Advancing Translational Sciences (no department on record)
From the FY2019 NIH awards this investigator leads as contact PI. The department is the award's.
- Top 1% Funded
- Rising Star
- Early Career
NIH Funding · FY2019
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
View yearly values
| Fiscal year | Linked awards | Records | Rank |
|---|---|---|---|
| 2018 | $769,646 | 5 | #10,671 |
| 2019 | $11,378,682 | 7 | #155 |
| 2021 | $21,252,122 | 7 | #75 |
| 2022 | $32,107,610 | 11 | #43 |
Award activity
Awards through the years
NIH award records listing this researcher in each fiscal year.
- FY20185 records
- FY2019 · selected7 records
- FY20217 records
- FY202211 records
Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.
Publications
Loading publications…
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2018 through FY2022Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2019 award records by amount
NIH award records listing Lo, Donald as a PI. Multi-PI records show the full award amount for context.
- 1ZIATR000375-01ZIAContact PIHEAL: Development of Clinical Candidate Drugs for Pain, Addiction and Overdose$9.6Maward amount
- 1ZIATR000374-01ZIAContact PIBPN14770 For Treatment of Fragile X Syndrome$585Kaward amount
- 1ZIATR000278-03ZIAContact PIMetarrestin for the Treatment of Pancreatic Cancer$543.7Kaward amount
- 1ZIATR000019-05ZIAContact PIStudies of Tumor-Penetrating Microparticles for Pancreatic Cancer$185.6Kaward amount
- 1ZIATR000029-05ZIAContact PIPeripheral CB1 Receptor Antagonist for Therapeutic Use in Metabolic Syndrome$168.5Kaward amount
- 1ZIATR000036-05ZIAContact PIDevelopment of an ApoA-1 Mimetic Peptide for Treatment of Atherosclerosis$156.3Kaward amount
- 1ZIATR000026-05ZIAContact PIEvaluation of ACT1 to Treat Diabetic Keratopathy$152.3Kaward amount
Award organization
Organizations that administered FY2019 awards listing Lo, Donald as a PI.
FY2019 award administered by National Center for Advancing Translational Sciences ().
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2018First NIH AwardNational Center for Advancing Translational Sciences
- 2018$500K Cumulative Funding
- 2019$1M Cumulative Funding
- 2019$2M Cumulative Funding
- 2019$5M Cumulative Funding
- 2019$10M Cumulative Funding
- 2019Entered Top 50% NationallyRanked #155
- 2019Entered Top 25% NationallyRanked #155
- 2019Entered Top 10% NationallyRanked #155
- 2019Entered Top 5% NationallyRanked #155
- 2019Entered Top 1% NationallyRanked #155
- 2021$25M Cumulative Funding
- 2022$50M Cumulative Funding